Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Short term Debt: 2010-2025

Historic Short term Debt for Arrowhead Pharmaceuticals (ARWR) over the last 9 years, with Sep 2025 value amounting to $40.0 million.

  • Arrowhead Pharmaceuticals' Short term Debt was N/A to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year change of. This contributed to the annual value of $40.0 million for FY2025, which is N/A change from last year.
  • According to the latest figures from FY2025, Arrowhead Pharmaceuticals' Short term Debt is $40.0 million, which was up 5,654.45% from $695,114 recorded in FY2017.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Short term Debt peaked at $40.0 million during FY2025, and registered a low of $40.0 million during FY2025.
  • In the last 1 years, Arrowhead Pharmaceuticals' Short term Debt had a median value of $40.0 million in 2025 and averaged $40.0 million.